Lucid Diagnostics Q1 2024 Adj EPS $(0.21) Beats $(0.27) Estimate, Sales $1.001M Miss $1.046M Estimate
Lucid Diagnostics Q1 2024 Adj EPS $(0.21) Beats $(0.27) Estimate, Sales $1.001M Miss $1.046M Estimate
Lucid Diagnostics 2024年第一季度调整后每股收益美元（0.21）超过预期（0.27）美元，销售额为10.46万美元的预期
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.27) by 22.22 percent. This is a 12.5 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $1.001 million which missed the analyst consensus estimate of $1.046 million by 4.33 percent. This is a 124.44 percent increase over sales of $446.000 thousand the same period last year.
Lucid Diagnostics（纳斯达克股票代码：LUCD）公布的季度亏损为每股0.21美元，比分析师普遍预期的0.27美元（0.27美元）高出22.22％。这比去年同期每股亏损0.24美元（0.24美元）增长了12.5％。该公司公布的季度销售额为10.1万美元，比分析师普遍预期的10.46亿美元低4.33％。这比去年同期的44.6万美元销售额增长了124.44％。